FUNDAMENTALS · Fundamentals · JP Healthcare

EM Systems (4820) Fundamentals 2026 — P/E 25.6x, Revenue Analysis | SniperIQ

EM Systems (4820) is a JP-listed Healthcare company in Medical - Healthcare Information Services with a market capitalization of ¥37.6B, trading at ¥543.00 on the JPX. This SniperIQ fundamentals page covers EM Systems's valuation (P/E 25.6x, P/B 2.0x), profitability (net margin 6.7%), revenue (¥23.7B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.

Market Cap¥37.6B
P/E (TTM)25.6x
Net Margin6.7%
Revenue (FY25)¥23.7B

Full research coverage

  • 8-Quarter Revenue & Margin Trend
  • Debt Maturity & Coverage
  • Peer Valuation Comparison
  • Free Cash Flow & Owner Earnings
  • AI Signal + Institutional Flow
  • DCF Valuation Model

Frequently Asked Questions

What is EM Systems's market cap?

EM Systems (4820) has a market capitalization of approximately ¥37.6B, trading at ¥543.00 on the JPX. Market cap moves with the live share price.

What is EM Systems's P/E ratio?

EM Systems's trailing twelve-month P/E ratio is 25.6x, with a price-to-book (P/B) of 2.0x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.

How profitable is EM Systems?

EM Systems runs a net profit margin of 6.7%, a gross margin of 45.4%, and an operating margin of 10.7%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.

How much revenue does EM Systems generate?

EM Systems reported revenue of ¥23.7B for fiscal year 2025, with net income of ¥2.5B and earnings per share (EPS) of 35.44. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.

Does EM Systems pay a dividend?

EM Systems offers a trailing dividend yield of about 5.0%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.

Is EM Systems financially healthy?

EM Systems carries a debt-to-equity ratio of 0.04x and a current ratio of 2.05x, with a market beta of 0.52. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.

Is EM Systems a good stock to buy in 2026?

SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For EM Systems (4820) the key facts are: market cap ¥37.6B, P/E 25.6x, revenue ¥23.7B, 52-week range 482-847. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.

Track EM Systems's full fundamentals live

Get EM Systems's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.

Related: Aarti Drugs (AARTIDRUGS) fundamentals · Oncocross (382150) fundamentals · Natera (NTRA) fundamentals · Unichem Laboratories (UNICHEMLAB) fundamentals · All stock fundamentals · AI signal library
Research Hubs: Fundamentals library · Screeners · Institutional positioning · Super investors · Daily signals · Platform comparisons